News
Retrospective Analysis of Women with Only Mastalgia
Oct 01, 2016
The authors highlighted CRICO’s Breast Care Management Algorithm in their discussion and conclusion, which stated “According to researchers, 0.5% of the women with mastalgia were diagnosed with breast cancer. In our study this rate was found as 0.2%. Women with only mastalgia without any abnormality in physical examination should be informed about dealing with pain.”
Citation for the Full-text Article
Arslan M, Küçükerdem HS, Can H, Tarcan E. Retrospective Analysis of Women with Only Mastalgia. J Breast Health 2016; 12: 151-4. DOI: 10.5152/tjbh.2016.2944
Latest News from CRICO
Get all your medmal and patient safety news here.
Postpartum Malpractice Claims: Can We Understand Preventable Harms and Socioeconomic Factors?
News
In a multifactorial study, The Doctors Company (a Candello member organization) investigated postpartum claims to develop clinical recommendations to decrease the risks of postpartum morbidity and mortality.
Assessing the Impact of Hospital Mergers and Acquisitions on Safety Culture with Proactive Risk Assessments
News
Hospitals seeking to understand patient safety strengths and vulnerabilities in the context of mergers/acquisitions benefit more from a third-party perspective than from a limited internal process. CRICO’s Risk Assessment Unit has access to a rich body of work to help articulate identified factors and by which to frame improvement recommendations.
How Does Work Environment Relate to Diagnostic Quality? A Prospective, Mixed Methods Study in Primary Care
News
CRICO Grants
The aim of this CRICO-funded study was to develop a tool assessing key elements of the diagnostic assessment process and apply it to a series of diagnostic encounters examining clinical notes and encounters' recorded transcripts.
Developing a Framework and Electronic Tool for Communicating Diagnostic Uncertainty in Primary Care: A Qualitative Study
News
CRICO Grants
This CRICO-funded study asked, “What are clinician and patient perspectives and innovative ways to communicate diagnostic uncertainty to patients?”